Markets
MRK

Company News For Oct 11, 2017

Highs and Lows Stock Data

  • Shares Barracuda Networks, Inc. CUDA gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million
  • Merck & Co., Inc.'s MRK shares gained 0.2% after the company purchased a 9.9% stake in KalVista Pharmaceuticals Inc. KALV at a price of $8.50 per share
  • AnaptysBio, Inc.'s ANAB shares rallied 101.2% after the company announced positive results and proof-of-concept data from Phase 2a trial of it drug ANB020 In used for the treatment atopic dermatitis
  • Shares of Hudson Technologies Inc. HDSN declined 0.8% after the company lowered its third quarter 2017 earnings guidance to $0.03-$0.05 a share from $0.10 per share earlier

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Barracuda Networks, Inc. (CUDA): Free Stock Analysis Report

Merck & Company, Inc. (MRK): Free Stock Analysis Report

Hudson Technologies, Inc. (HDSN): Free Stock Analysis Report

AnaptysBio, Inc. (ANAB): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRK ANAB HDSN KALV

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More